Cancer Research UK and Cancer Research Technology join forces with Astellas on autophagy to find new cancer treatments
Cancer Research UK and its commercial arm, Cancer Research Technology are to join forces with Astellas Pharma Inc.
An experimental treatment that uses microscopic balls – called ‘nanoparticles’ – could be used to target cancer cells within bones.
Experimental drugs being tested in clinical trials for leukaemia may also boost the body’s immune response against other forms of cancer.
Routine tests that look for multiple, specific genetic changes in patients’ lung tumours could help doctors select targeted treatments.
Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership
Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer
CRT and Teva’s collaboration yields successful outcome with novel aPKC protein inhibitor cancer drug development candidate
CRT announces a successful outcome to collaborating with Teva - identiying a novel atypical Protein Kinase C (aPKC) inhibitor pre-clinical candidate.
Patients with advanced bowel cancer are set to benefit from the launch of a new clinical trial targeting treatments to their specific cancer type
A new cancer drug, RG7813, developed after a discovery made by Cancer Research UK, has entered a clinical trial targeting a wide range of cancers.
We talk about a study that could revolutionise breast cancer treatment, growing evidence on aspirin and cancer, and the latest cancer trends.